Speaker

Mike Wan

Senior Manager of Clinical Pharmacology, Gilead Sciences

Mike Wan, Senior Manager of Clinical Pharmacology at Gilead Sciences, spoke at 2nd T-Cell Engager for Autoimmune Disease Summit (Boston, United States of America, 27–29 Oct 2026) in the session “Workshop A: Engineering Autoimmune T-Cell Engager Constructs to Maximize Targeted Cell Depletion While Minimizing Cytokine Release”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

2nd T-Cell Engager for Autoimmune Disease Summit
27–29 Oct 2026Boston, United States of America
- WorkshopWorkshop A: Engineering Autoimmune T-Cell Engager Constructs to Maximize Targeted Cell Depletion While Minimizing Cytokine Release
- PanelPanel Discussion: Harnessing Co-Stimulation to Enhance T-Cell Persistence, Overcome Exhaustion & Unlock Durable Autoimmune ResponsesWith Alexander Boches

More speakers at 2nd T-Cell Engager for Autoimmune Disease Summit

Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Giovanni Abbadessa
Chief Medical Officer, ModeX Therapeutics
Patrick Baeuerle
Chief Scientific Advisor & Chairman of Scientific Advisory Board, Cullinan Therapeutics, Inc.
Xingfeng Bao
Senior Vice President & Head of Research, GV20 Therapeutics LLC
Elaine Chen
Senior Scientist, Translational Biology, Rondo Therapeutics
David de Graaf
Co-Founder, CEO & President, Reverb Therapeutics Inc.

See all 20 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mike Wan, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].